This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as a Hybrid Event from September 20-30, 2021
Live In-Person Experience Delivered September 20-23Boston Convention and Exhibition Center

Anna French
Principal at Qiming Venture Partners USA

Profile

Anna French, PhD is a Partner at Qiming Venture Partners USA, and is based in Cambridge, MA. Prior to joining the Qiming team in 2017, Anna was a management consultant at the Boston Consulting Group (BCG) where she advised leading biopharma companies on their strategy and operations. She also led a global industry-academic consortium focused on cell therapy commercialization.

Anna earned a D.Phil from the University of Oxford, UK where her research focused on hematological differentiation of human induced pluripotent stem (iPS) cells. She has over 20 publications in the field of stem cell research.

Anna currently serves on the boards of WindMIL Therapeutics, Jasper Therapeutics, Umoja Biopharma and Auron Therapeutics and is a board observer with Talaris Therapeutics, and PlateletBio.

Agenda Sessions

  • ROOM 210A: Panel: Investment view on Innovation in Cell & Gene Therapy

    9:00am